Live news related to ABIONYX PHARMA stock (FR0012616852): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on ABIONYX PHARMA mainly cover M&A activity. The stock trades at €1,95 on Euronext Paris, down 3,18% at the last update. This page lists the articles published on ABIONYX PHARMA stock to track the share price, company announcements and any item likely to influence market perception.
The Toulouse-based biotech suffers a heavy stock market penalty on Thursday morning, the day it finalized its capital increase. The stock is among the…
French biopharmaceutical company Abionyx Pharma announced on Thursday the successful completion of its capital increase of €18.7M and the submission o…
Abionyx Pharma announced this Wednesday the launch of a 100% secured capital increase amounting to €18.7 million, supplemented by a bond financing tha…
ABIONYX Pharma announces the development of a new manufacturing process for synthetic sphingomyelin, a key component of its CER-001 product for sepsis…
ABIONYX Pharma announces its annual results for 2025 and outlines its strategic directions focused on actively preparing for the next clinical phase i…
